Institut Cochin, INSERM, CNRS, Université Paris Cité, Paris, F75014, France.
Institut Cochin, INSERM, CNRS, Université Paris Cité, Paris, F75014, France.
Respir Physiol Neurobiol. 2022 Oct;304:103939. doi: 10.1016/j.resp.2022.103939. Epub 2022 Jun 29.
While administration of the cyclic redox agent methylene blue (MB) during intoxication by mitochondrial poisons (cyanide, hydrogen sulfide, rotenone) increases survival, the mechanisms behind these antidotal properties remain poorly understood. The objective of the studies presented in this paper was to characterize the interactions between the redox properties of MB, the intermediate metabolism and the mitochondrial respiration. We first show that intra-venous administration of micromolar levels of methylene blue in sedated and mechanically ventilated rats, increases not only resting oxygen consumption but also CO production (by ~ 50%), with no change in their ratio. This hypermetabolic state could be reproduced in a cellular model, where we found that the rate of electron transfer to MB was of the same order of magnitude as that of normal cellular metabolism. Notably, the large increase in cellular oxygen consumption caused by MB was relatively indifferent to the status of the mitochondrial respiratory chain: oxygen consumption persisted even when the respiratory chain was inhibited or absent (using inhibitors and cells deficient in mitochondrial oxidative phosphorylation); yet MB did not impede mitochondrial ATP production in control conditions. We present evidence that after being reduced into leuco-methylene blue (LMB) in presence of reducing molecules that are physiologically found in cells (such as NADH), the re-oxidation of LMB by oxygen can account for the increased oxygen consumption observed in vivo. In conditions of acute mitochondrial dysfunction, these MB redox cycling properties allow the rescue of the glycolysis activity and Krebs cycle through an alternate route of oxidation of NADH (or other potential reduced molecules), which accumulation would have otherwise exerted negative feedback on these metabolic pathways. Our most intriguing finding is that re-oxidization of MB by oxygen ultimately results in an in vivo matching between the increase in the rate of O consumed, by MB re-oxidation, and the rate of CO, produced by the intermediate metabolism, imitating the fundamental coupling between the glycolysis/Krebs cycle and the mitochondrial respiration.
虽然在中毒(氰化物、硫化氢、鱼藤酮)时使用循环氧化还原试剂亚甲蓝(MB)可提高存活率,但这些解毒特性的机制仍知之甚少。本文介绍的研究目的是描述 MB 的氧化还原特性、中间代谢和线粒体呼吸之间的相互作用。我们首先表明,静脉内给予镇静和机械通气大鼠亚微米级别的 MB,不仅增加了静息耗氧量,还增加了 CO 产生(约 50%),但其比值不变。在细胞模型中可以重现这种代谢亢进状态,我们发现,MB 向电子的转移速率与正常细胞代谢的速率相同。值得注意的是,MB 引起的细胞耗氧量的大量增加相对不依赖于线粒体呼吸链的状态:即使呼吸链被抑制或不存在(使用抑制剂和缺乏线粒体氧化磷酸化的细胞),耗氧量仍然持续;然而,MB 在对照条件下并不阻碍线粒体 ATP 的产生。我们提出的证据表明,在生理上存在于细胞中的还原分子(如 NADH)存在下,MB 被还原为无色亚甲蓝(LMB)后,LMB 被氧重新氧化,可以解释在体内观察到的耗氧量增加。在急性线粒体功能障碍的情况下,这些 MB 氧化还原循环特性允许通过 NADH(或其他潜在的还原分子)的替代氧化途径来挽救糖酵解活性和三羧酸循环,否则这些代谢途径的积累将对这些代谢途径产生负反馈。我们最有趣的发现是,氧对 MB 的再氧化最终导致体内 MB 再氧化所增加的 O 消耗率与中间代谢所产生的 CO 产生率相匹配,模拟了糖酵解/三羧酸循环和线粒体呼吸之间的基本偶联。